Brian D Berman1,2, Jason Smucny3, Korey P Wylie3, Erika Shelton1, Eugene Kronberg3, Maureen Leehey1, Jason R Tregellas3,4. 1. Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. 2. Neurology Section, Denver VA Medical Center, Denver, Colorado, USA. 3. Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. 4. Research Service, Denver VA Medical Center, Denver, Colorado, USA.
Abstract
BACKGROUND: PD is associated with disrupted connectivity to a large number of distributed brain regions. How the disease alters the functional topological organization of the brain, however, remains poorly understood. Furthermore, how levodopa modulates network topology in PD is largely unknown. The objective of this study was to use resting-state functional MRI and graph theory to determine how small-world architecture is altered in PD and affected by levodopa administration. METHODS: Twenty-one PD patients and 20 controls underwent functional MRI scanning. PD patients were scanned off medication and 1 hour after 200 mg levodopa. Imaging data were analyzed using 226 nodes comprising 10 intrinsic brain networks. Correlation matrices were generated for each subject and converted into cost-thresholded, binarized adjacency matrices. Cost-integrated whole-brain global and local efficiencies were compared across groups and tested for relationships with disease duration and severity. RESULTS: Data from 2 patients and 4 controls were excluded because of excess motion. Patients off medication showed no significant changes in global efficiency and overall local efficiency, but in a subnetwork analysis did show increased local efficiency in executive (P = 0.006) and salience (P = 0.018) networks. Levodopa significantly decreased local efficiency (P = 0.039) in patients except within the subcortical network, in which it significantly increased local efficiency (P = 0.007). CONCLUSIONS: Levodopa modulates global and local efficiency measures of small-world topology in PD, suggesting that degeneration of nigrostriatal neurons in PD may be associated with a large-scale network reorganization and that levodopa tends to normalize the disrupted network topology in PD.
BACKGROUND:PD is associated with disrupted connectivity to a large number of distributed brain regions. How the disease alters the functional topological organization of the brain, however, remains poorly understood. Furthermore, how levodopa modulates network topology in PD is largely unknown. The objective of this study was to use resting-state functional MRI and graph theory to determine how small-world architecture is altered in PD and affected by levodopa administration. METHODS: Twenty-one PDpatients and 20 controls underwent functional MRI scanning. PDpatients were scanned off medication and 1 hour after 200 mg levodopa. Imaging data were analyzed using 226 nodes comprising 10 intrinsic brain networks. Correlation matrices were generated for each subject and converted into cost-thresholded, binarized adjacency matrices. Cost-integrated whole-brain global and local efficiencies were compared across groups and tested for relationships with disease duration and severity. RESULTS: Data from 2 patients and 4 controls were excluded because of excess motion. Patients off medication showed no significant changes in global efficiency and overall local efficiency, but in a subnetwork analysis did show increased local efficiency in executive (P = 0.006) and salience (P = 0.018) networks. Levodopa significantly decreased local efficiency (P = 0.039) in patients except within the subcortical network, in which it significantly increased local efficiency (P = 0.007). CONCLUSIONS:Levodopa modulates global and local efficiency measures of small-world topology in PD, suggesting that degeneration of nigrostriatal neurons in PD may be associated with a large-scale network reorganization and that levodopa tends to normalize the disrupted network topology in PD.
Authors: Clare Kelly; Greig de Zubicaray; Adriana Di Martino; David A Copland; Philip T Reiss; Donald F Klein; F Xavier Castellanos; Michael P Milham; Katie McMahon Journal: J Neurosci Date: 2009-06-03 Impact factor: 6.167
Authors: Ming-Ching Wen; Samuel Y E Ng; Hannah S E Heng; Yin Xia Chao; Ling Ling Chan; Eng King Tan; Louis C S Tan Journal: Parkinsonism Relat Disord Date: 2016-01-12 Impact factor: 4.891
Authors: Manfred G Kitzbichler; Richard N A Henson; Marie L Smith; Pradeep J Nathan; Edward T Bullmore Journal: J Neurosci Date: 2011-06-01 Impact factor: 6.167
Authors: Deepti Putcha; Robert S Ross; Alice Cronin-Golomb; Amy C Janes; Chantal E Stern Journal: Neuroimage Clin Date: 2015-01-27 Impact factor: 4.891
Authors: Jason Smucny; Korey P Wylie; Eugene Kronberg; Kristina T Legget; Jason R Tregellas Journal: J Psychiatr Res Date: 2017-02-03 Impact factor: 4.791
Authors: Sandra M S F Freitas; Paulo B de Freitas; Ali Falaki; Tyler Corson; Mechelle M Lewis; Xuemei Huang; Mark L Latash Journal: Exp Brain Res Date: 2020-10-17 Impact factor: 1.972
Authors: Jinhee Kim; Marion Criaud; Sang Soo Cho; María Díez-Cirarda; Alexander Mihaescu; Sarah Coakeley; Christine Ghadery; Mikaeel Valli; Mark F Jacobs; Sylvain Houle; Antonio P Strafella Journal: Brain Date: 2017-11-01 Impact factor: 13.501
Authors: Xueling Suo; Du Lei; Wenbin Li; Lei Li; Jing Dai; Song Wang; Nannan Li; Lan Cheng; Rong Peng; Graham J Kemp; Qiyong Gong Journal: Front Med Date: 2020-05-26 Impact factor: 4.592